Bio Green Med Solution (BGMS) Work In Process (2025)
Bio Green Med Solution (BGMS) posted quarterly Work In Process of $134000.0 for Q4 2025, up 3.88% quarter-over-quarter from $129000.0 in Q3 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Work In Process (2025) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Work In Process for 1 consecutive years, with $134000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Work In Process changed N/A year-over-year to $134000.0; the TTM figure through Dec 2025 stood at $134000.0 (changed N/A YoY), while the FY2025 annual figure was $134000.0, changed N/A from the prior year.
- Work In Process climbed to $134000.0 in Q4 2025 per BGMS's latest filing, from $129000.0 in the prior quarter.
- Across five years, Work In Process topped out at $134000.0 in Q4 2025 and bottomed at $129000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.68 Bn | 133.83 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.47 Bn | 79.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.12 Bn | 52.98 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 40.55 Bn | 35.45 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.15 Bn | 27.31 Bn | - |
| 9 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.50 Mn | 1.71 Mn | 79,000.00 |